No Data
No Data
Kane to Host Investor Webinar – What Kane Has in Store for 2025 Including the Acquisition of FB Dermatology
Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering
Kane Biotech Inc (KNBIF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Milestones
Kane Biotech Narrows Its Third-Quarter Loss as Revenue Rises
Kane Biotech Brief: Net Loss From Continuing Operations for the Third Quarter of 2024 Was $(678,636)
Kane Biotech Reports Change in U.S. Distribution Partner for Revyve Gel